Octavia Wealth Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 869 shares of the healthcare conglomerate’s stock after purchasing an additional 32 shares during the period. Octavia Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $458,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Robbins Farley purchased a new stake in UnitedHealth Group in the 3rd quarter worth about $25,000. Richelieu Gestion SA purchased a new stake in UnitedHealth Group in the 4th quarter worth about $26,000. CGC Financial Services LLC lifted its stake in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC lifted its stake in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its stake in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
UNH opened at $469.14 on Wednesday. The stock’s 50 day moving average price is $490.31 and its two-hundred day moving average price is $515.63. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a market capitalization of $432.51 billion, a P/E ratio of 19.68, a price-to-earnings-growth ratio of 1.22 and a beta of 0.54.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.
Analyst Upgrades and Downgrades
UNH has been the topic of several research reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $573.80.
Read Our Latest Research Report on UnitedHealth Group
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What Are Dividend Achievers? An Introduction
- Prologis Stock Leading U.S. Logistics Boom
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
- 3 Small Caps With Big Return Potential
- Are We in a Bull Market? 4 Factors that Determine a Bull Market
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.